Financhill
Back

Karyopharm Therapeutics Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
34

KPTI
Karyopharm Therapeutics

Last Price:
0.84
Seasonality Move:
8.59%
Sell
25

DRUG
Bright Minds Biosciences

Last Price:
46.84
Seasonality Move:
-24.57%
Sell
34
Karyopharm Therapeutics (KPTI) is a Sell

Is Karyopharm Therapeutics a Buy, Sell or Hold?

  • The current Karyopharm Therapeutics [KPTI] share price is $0.83. The Score for KPTI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $46.55. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KPTI Stock Price Chart

What is Karyopharm Therapeutics's stock price today?

  • The Karyopharm Therapeutics share price today is $0.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $46.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

KPTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 47.62 Sell
Chaikin Money Flow: -132331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.81 - 0.91) Sell
Bollinger Bands (100): (0.76 - 0.92) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.95 Buy
Relative Strength Index (14 RSI): 61.69 Buy
Chaikin Money Flow: -16145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.09 - 49.25) Buy
Bollinger Bands (100): (-4.86 - 35.5) Buy

KPTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.83 Sell
20-day SMA: 0.85 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1 Sell
8-day EMA: 0.84 Sell
20-day EMA: 0.84 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.35 Buy
20-day SMA: 42.22 Buy
50-day SMA: 29.51 Buy
200-day SMA: 8.28 Buy
8-day EMA: 40.89 Buy
20-day EMA: 39.84 Buy
50-day EMA: 31.67 Buy
200-day EMA: 13.3 Buy

Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Karyopharm Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):